Related Experiment Video
Updated: Mar 10, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation
Mingxing Zheng1, Zhibing Zhu2, Yongzhao Zhao3
1Department of Respiratory Medicine, Clinical College of Anhui Medical University Affiliated Shenzhen Second People's Hospital, Shenzhen, Guangdong 518035, P.R. China.
Abstract:
Previous studies have demonstrated that oridonin, a tetracyclic diterpenoid compound extracted from Rabdosia rubescens, inhibits proliferation and induces apoptosis in several tumor cell lines. However, the mechanism by which oridonin inhibits the cell cycle remains poorly understood. In the present study, possible mechanisms by which oridonin affects cell cycle progression were explored in A549 lung cancer cells. Flow cytometry analysis indicated that oridonin inhibited the proliferation of A549 cells by inducing G2/M cell cycle arrest in a dose‑dependent manner. Western blot analysis revealed that in oridonin treated cells, phosphorylated (p‑)ATM serine/threonine kinase (S1981), p‑checkpoint kinase 2 (CHK2) (T68), p‑p53, and phosphorylated H2A histone family member X protein levels were visibly increased, indicating that oridonin promoted G2/M arrest in A549 cells through the ATM‑p53‑CHK2 pathway. This data suggests that oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation, which is likely a common mechanism in other tumor cell types when using this drug for cancer treatment.
Insights
Oridonin halts lung cancer cell growth by triggering cell cycle arrest. This occurs via the ATM-p53-CHK2 pathway, offering a potential cancer treatment mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Oridonin, derived from Rabdosia rubescens, is known to inhibit tumor cell proliferation and induce apoptosis.
- The precise mechanisms by which oridonin influences cell cycle progression are not fully elucidated.
Purpose of the Study:
- To investigate the mechanisms underlying oridonin-induced cell cycle arrest in A549 lung cancer cells.
- To explore the role of the ATM-p53-CHK2 pathway in oridonin's anti-cancer effects.
Main Methods:
- Cell cycle analysis using flow cytometry.
- Western blot analysis to detect key protein phosphorylation levels (ATM, CHK2, p53, H2AX).
Main Results:
- Oridonin induced a dose-dependent G2/M cell cycle arrest in A549 lung cancer cells.
- Treatment with oridonin increased the phosphorylation of ATM, CHK2, p53, and H2AX.
- These findings suggest the involvement of the ATM-p53-CHK2 signaling pathway.
Conclusions:
- Oridonin promotes G2/M cell cycle arrest in A549 lung cancer cells.
- The mechanism involves the activation of the ATM-p53-CHK2 pathway.
- This pathway activation may be a common mechanism for oridonin's anti-cancer activity in various tumor types.
More Related Videos
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...

